Also from this source

Aug 14, 2018, 12:29 ET Portage to Acquire SalvaRx Limited...


You just read:

Biohaven' BHV-0223 is Granted Orphan Drug Designation in the Treatment of Amyotrophic Lateral Sclerosis

News provided by

Portage Biotech Inc.

Dec 09, 2016, 09:00 EST